LRRK2 and Parkinson disease: IL-1β can also be elevated in PD patient serum [64,65], including in potential prodromal states of PD such as is plasma from asymptomatic carriers of the LRRK2 mutation [66], and CSF from patients with REM sleep behaviour disorder [67].